Type I diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Written consent of the patient (14 years and older) and parents (or guardians) to participate in the study and the associated collection and storage of data 2) Type 1 diabetes mellitus 3) Age under 18 years 4) Sufficient knowledge of the German language to participate in the survey
Exclusion criteria
Exclusion criteria: 1) Refusal of participation by the patient or parents (or guardians) 2) No guardian present 3) Refusal of participation by the attending physician of the study centre 4) No fulfilment of the other inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of drug-related problems in the emergency management of metabolic decompensations, assessed via a semi-structured interview including observation of drug demonstrations on a model | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Number and severity of metabolic decompensations experienced within the past year 2) Type and date of the last training received on metabolic decompensations 3) Results of the questionnaire for subjective perception of the relevance of ketoacidosis and hypoglycaemia in everyday life | — |
Countries
Germany
Contacts
ZAMS - Zentrum für Arzneimittelsicherheit, Universität und Universitätsklinikum LeipzigKlinische Pharmazie, Institut für Pharmazie, Medizinische Fakultät, Universität Leipzig